Riverhead Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $638K | Buy |
6,517
+800
| +14% | +$78.3K | 0.02% | 618 |
|
|
2019
Q2 | $749K | Sell |
5,717
-2,913
| -34% | -$382K | 0.03% | 582 |
|
|
2019
Q1 | $1.17M | Buy |
8,630
+2,075
| +32% | +$281K | 0.05% | 438 |
|
|
2018
Q4 | $638K | Buy |
6,555
+82
| +1% | +$7.98K | 0.03% | 572 |
|
|
2018
Q3 | $900K | Buy |
6,473
+100
| +2% | +$13.9K | 0.03% | 515 |
|
|
2018
Q2 | $791K | Buy |
6,373
+613
| +11% | +$76.1K | 0.03% | 519 |
|
|
2018
Q1 | $642K | Sell |
5,760
-132
| -2% | -$14.7K | 0.03% | 552 |
|
|
2017
Q4 | $705K | Buy |
5,892
+1,225
| +26% | +$147K | 0.03% | 535 |
|
|
2017
Q3 | $655K | Sell |
4,667
-700
| -13% | -$98.2K | 0.03% | 515 |
|
|
2017
Q2 | $653K | Buy |
5,367
+399
| +8% | +$48.5K | 0.03% | 500 |
|
|
2017
Q1 | $602K | Buy |
4,968
+801
| +19% | +$97.1K | 0.03% | 482 |
|
|
2016
Q4 | $510K | Sell |
4,167
-600
| -13% | -$73.4K | 0.03% | 493 |
|
|
2016
Q3 | $584K | Sell |
4,767
-89,261
| -95% | -$10.9M | 0.04% | 426 |
|
|
2016
Q2 | $872K | Buy |
94,028
+76,343
| +432% | +$708K | 0.03% | 465 |
|
|
2016
Q1 | $2.46M | Sell |
17,685
-8,752
| -33% | -$1.22M | 0.03% | 469 |
|
|
2015
Q4 | $5.04M | Buy |
26,437
+595
| +2% | +$113K | 0.07% | 326 |
|
|
2015
Q3 | $4.04M | Sell |
25,842
-1,449
| -5% | -$227K | 0.06% | 335 |
|
|
2015
Q2 | $4.93M | Buy |
27,291
+1,380
| +5% | +$249K | 0.07% | 323 |
|
|
2015
Q1 | $4.49M | Buy |
25,911
+713
| +3% | +$124K | 0.07% | 326 |
|
|
2014
Q4 | $4.66M | Sell |
25,198
-152
| -0.6% | -$28.1K | 0.07% | 309 |
|
|
2014
Q3 | $4.21M | Buy |
25,350
+2,717
| +12% | +$451K | 0.07% | 313 |
|
|
2014
Q2 | $3.54M | Buy |
22,633
+4,060
| +22% | +$634K | 0.07% | 332 |
|
|
2014
Q1 | $2.83M | Buy |
18,573
+772
| +4% | +$117K | 0.06% | 341 |
|
|
2013
Q4 | $2.37M | Buy |
17,801
+6,801
| +62% | +$904K | 0.06% | 320 |
|
|
2013
Q3 | $1.28M | Hold |
11,000
| – | – | 0.04% | 323 |
|
|
2013
Q2 | $1.01M | Buy |
+11,000
| New | +$1.01M | 0.03% | 339 |
|